journal article·2024-09Open access

A Biomimetic Leaflet Scaffold for Aortic Valve Remodeling

Kenneth J. De Jesus Morales, Utari Santosa, Olga Brazhkina, Pranshu Rajurkar, Hanjoong Jo, Michael E. Davis

Advanced Healthcare Materials· Volume 13· Issue 23

Abstract

Abstract Heart valve disease poses a significant clinical challenge, especially in pediatric populations, due to the inability of existing valve replacements to grow or respond biologically to their microenvironment. Tissue‐engineered heart valves (TEHVs) provide a solution by facilitating patient‐specific models for self‐repair and remodeling. In this study, a 3D‐bioprinted TEHV is designed to emulate the trilayer leaflet structure of an aortic valve. A cell‐laden hydrogel scaffold made from gelatin methacrylate and polyethylene glycol diacrylate (GelMA/PEGDA) incorporates valvular interstitial‐like (VIC‐like) cells, being reinforced with a layer of polycaprolactone (PCL). The composition of the hydrogel scaffold remains stable over 7 days, having increased mechanical strength compared to pure GelMA. The scaffold maintains VIC‐like cell function and promotes extracellular matrix (ECM) protein expression up to 14 days under two dynamic culture conditions: shear stress and stretching; replicating heart valve behavior within a more physiological‐like setting and suggesting remodeling potential via ECM synthesis. This TEHV offers a promising avenue for valve replacements, closely replicating the structural and functional attributes of a native aortic valve, leading to mechanical and biological integration through biomaterial–cellular interactions.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Cardiac Valve Diseases and Treatments · Cardiac and Coronary Surgery Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Wallace H. Coulter Department of Biomedical Engineering Emory University School of Medicine & Georgia Institute of Technology Atlanta GA 30322 USA

Division of Cardiology Department of Medicine Emory University Atlanta GA 30322 USA

Children's Heart Research & Outcomes (HeRO) Center Children's Healthcare of Atlanta & Emory University Atlanta GA 30322 USA

Funding

National Science Foundation

References (47)

Show source-provided references
1. 10.1016/S0140-6736(06)69208-810.1016/S0140-6736(06)69208-8 ↗
2. Bach D. S. · J. Heart Valve Dis. · 2007 · 16 · 362
3. c)Aortic Valve Disease.American Heart Association 2020.
4. 10.1038/ncpcardio011210.1038/ncpcardio0112 ↗
5. 10.1016/j.acvd.2012.02.01310.1016/j.acvd.2012.02.013 ↗
6. 10.1146/annurev-bioeng-061008-12490310.1146/annurev-bioeng-061008-124903 ↗
7. 10.1016/j.jsha.2013.11.00310.1016/j.jsha.2013.11.003 ↗
8. 10.1016/j.cjca.2021.03.02210.1016/j.cjca.2021.03.022 ↗
9. 10.1002/adhm.20170091810.1002/adhm.201700918 ↗
10. 10.1126/science.aav905110.1126/science.aav9051 ↗
11. 10.3390/nano805029610.3390/nano8050296 ↗
12. Maxson E. L. · Int. J. Bioprint. · 2019 · 1610.1016/j.bprint.2019.e00059 ↗
13. 10.1517/14712598.2015.105152710.1517/14712598.2015.1051527 ↗
14. 10.1007/s10439-016-1676-510.1007/s10439-016-1676-5 ↗
15. 10.1089/ten.a.2007.014810.1089/ten.a.2007.0148 ↗
16. 10.1007/s10439-016-1778-010.1007/s10439-016-1778-0 ↗
17. 10.1007/s10439-016-1607-510.1007/s10439-016-1607-5 ↗
18. 10.1016/j.actbio.2013.12.00510.1016/j.actbio.2013.12.005 ↗
19. 10.1615/JLongTermEffMedImplants.201501181710.1615/JLongTermEffMedImplants.2015011817 ↗
20. 10.1016/j.actbio.2018.02.02510.1016/j.actbio.2018.02.025 ↗
21. 10.1016/j.biomaterials.2020.11983810.1016/j.biomaterials.2020.119838 ↗
22. 10.22203/eCM.v006a0410.22203/eCM.v006a04 ↗
23. 10.1016/j.actbio.2011.02.01810.1016/j.actbio.2011.02.018 ↗
24. 10.1161/01.RES.0000136520.07995.aa10.1161/01.RES.0000136520.07995.aa ↗
25. 10.1016/j.matbio.2010.09.00110.1016/j.matbio.2010.09.001 ↗
26. 10.1089/teb.2007.015010.1089/teb.2007.0150 ↗
27. 10.1002/adhm.20160111810.1002/adhm.201601118 ↗
28. 10.2353/ajpath.2007.07025110.2353/ajpath.2007.070251 ↗
29. 10.1002/jbm.a.3613310.1002/jbm.a.36133 ↗
30. 10.1073/pnas.130636911010.1073/pnas.1306369110 ↗
31. 10.1089/ten.tea.2020.011810.1089/ten.tea.2020.0118 ↗
32. 10.1016/j.biomaterials.2019.11949310.1016/j.biomaterials.2019.119493 ↗
33. 10.1016/j.biomaterials.2014.04.03910.1016/j.biomaterials.2014.04.039 ↗
34. 10.1002/adma.20130101610.1002/adma.201301016 ↗
35. 10.1002/adma.20130550610.1002/adma.201305506 ↗
36. 10.1016/0021-9290(92)90249-Z10.1016/0021-9290(92)90249-Z ↗
37. 10.1161/01.RES.47.5.79210.1161/01.RES.47.5.792 ↗
38. 10.3389/fcvm.2022.97573210.3389/fcvm.2022.975732 ↗
39. 10.1161/JAHA.117.00633910.1161/JAHA.117.006339 ↗
40. 10.1006/jsre.1994.110210.1006/jsre.1994.1102 ↗
41. 10.1152/ajpcell.00137.200710.1152/ajpcell.00137.2007 ↗
42. 10.1161/hc4601.09948910.1161/hc4601.099489 ↗
43. 10.1002/term.183610.1002/term.1836 ↗
44. 10.1038/s41598-018-25851-510.1038/s41598-018-25851-5 ↗
45. 10.3390/jcdd203021410.3390/jcdd2030214 ↗
46. 10.1002/adhm.20180067210.1002/adhm.201800672 ↗
47. 10.1002/adbi.20230012410.1002/adbi.202300124 ↗